Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review [0.03%]
单髁膝关节置换术和全膝关节置换术的经济评估系统评价及 meta 分析
Edward Burn,Alexander D Liddle,Thomas W Hamilton et al.
Edward Burn et al.
Background and objective: Patients with anteromedial arthritis who require a knee replacement could receive either a unicompartmental knee replacement (UKR) or a total knee replacement (TKR). This review has been undertak...
Can Price Transparency Contribute to More Affordable Patient Access to Medicines? [0.03%]
价格透明能否助力患者更便捷地获得药品？
Sabine Vogler,Kenneth R Paterson
Sabine Vogler
Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib [0.03%]
日本慢性淋巴细胞性白血病患者的疾病经济负担及ibrutinib上市的预算影响分析
Jörg Mahlich,Shinichiro Okamoto,Akiko Tsubota
Jörg Mahlich
Background: Ibrutinib was introduced in Japan in 2016 as a new oral treatment option for patients with relapsed/refractory (RR) chronic lymphocytic leukemia (CLL). There is increasing interest from the Japanese government...
Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II-III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial [0.03%]
基于HubBLe试验证据的II至III期内痔患者橡皮圈套扎与硬化剂注射治疗的成本效益分析
Abualbishr Alshreef,Allan J Wailoo,Steven R Brown et al.
Abualbishr Alshreef et al.
Aim: Haemorrhoids are a common condition, with nearly 30,000 procedures carried out in England in 2014/15, and result in a significant quality-of-life burden to patients and a financial burden to the healthcare system. Th...
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology [0.03%]
常见病与罕见病增量成本效果比差异——来自肿瘤学的一个案例分析
Kavisha Jayasundara,Murray Krahn,Muhammad Mamdani et al.
Kavisha Jayasundara et al.
Background: Incremental cost-effectiveness ratios (ICERs) are used to assess the value for money of new drugs. Many believe that ICERs for drugs that treat rare diseases are much higher than those of common drugs. Our obj...
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications [0.03%]
尼日利亚公共医疗保健机构治疗 uncomplicated 疟疾的费用评估及其影响
Charles C Ezenduka,Daniel Resende Falleiros,Brian B Godman
Charles C Ezenduka
Background: Accurate information on the facility costs of treatment is essential to enhance decision making and funding for malaria control. Objective: ...
Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study [0.03%]
促红细胞生成素经济性分析及其在血液透析患者治疗中的应用——一个试点研究
Astrid Darsonval,Virginie Besson,Claire Cavalin
Astrid Darsonval
Objective: This study aimed to assess the cost impact of administering erythropoiesis-stimulating agents once every 4 weeks instead of one to three times a week to treat anaemia in patients undergoing dialysis. ...
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review [0.03%]
基于模型的经济评估系统文献回顾——以抑郁症治疗为例
Spyros Kolovos,Judith E Bosmans,Heleen Riper et al.
Spyros Kolovos et al.
Background: An increasing number of model-based studies that evaluate the cost effectiveness of treatments for depression are being published. These studies have different characteristics and use different simulation meth...
Andreas Behr,Katja Theune
Andreas Behr
Background: Globally, health expenditure as a percentage of GDP has increased in recent years, so evaluating the health care systems used in different countries is an important tool for identifying best practices and impr...
Sachiko Ozawa,Tatenda T Yemeke,Alie F Tawah et al.
Sachiko Ozawa et al.
Background: Cambodia has one of the highest rates of overall medical injection usage worldwide. Therapeutic injections, which are often unnecessary, contribute to the spread of blood-borne diseases. ...